Scientists are rapidly investigating retatrutide, a promising medication created by Eli Lilly, as a significant breakthrough in body reduction . Different than many previous approaches, retatrutide is a dual -action compound targeting equally GLP-1 and GIP, hormones that impact appetite and bloo… Read More